Biotech Growth Investors & VC Firms
747 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.
Bonitás Ventures
BudapestSeries A–Late Stage$540K – $4.3M
19 people
Teralys Capital
MontrealGrowth
22 people
WELL Ventures
VancouverSeed–Growth
16 people
LYFE Capital
Menlo ParkSeed–Late Stage
17 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
New Mountain Capital
New YorkGrowth
6 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
Cowin Capital Group
ShenzhenSeed–Late Stage$1.4M – $50M
11 people
Waseda University Ventures
TokyoPre-Seed–Growth
8 people
America's Frontier Fund
ArlingtonPre-Seed–Growth$500K – $10M
13 people
Side Door Ventures
Fernandina BeachPre-Seed–Growth$300K – $5M
16 people
Bioventures Investors
WestboroughSeed–Late Stage$15M – $100M
15 people
Crescent Capital Partners
SydneySeries A–Late Stage$13.2M – $52.8M
18 people
Enterprise Investors Sp. z o. o.
WarsawSeries A–Growth$21.6M – $81M
24 people
Finance Yorkshire
BarnsleySeed–Growth
21 people
Grazia Equity GmbH
StuttgartSeed–Late Stage$540K – $2.7M
8 people
Revelation Partners
SausalitoGrowth–Late Stage$5M – $50M
17 people
Kobe University Capital
KobePre-Seed–Growth
10 people
DNA Capital
São PauloPre-Seed–Late Stage$100K – $5M
15 people
Xeraya Capital
Kuala LumpurSeed–Growth
20 people
Visionary Ventures
Newport BeachSeries A–Late Stage$5M – $15M
13 people
Breakthrough Victoria
MelbournePre-Seed–Late Stage
11 people
Partnership Fund for NYC
New York CitySeed–Growth
13 people
Capital Cell
BarcelonaPre-Seed–Growth
Related lists
Growth Investors & VC Firms (4757)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)Growth Investors & VC Firms in United States (1502)Growth Investors & VC Firms in Global (1414)Healthtech Growth Investors & VC Firms (1213)Enterprise Software Growth Investors & VC Firms (1186)SaaS Growth Investors & VC Firms (1173)Growth Investors & VC Firms in Europe (1149)
Data sourced from public filings and firms' own websites — see our methodology.







































































